Bristol-Myers Squibb Company

WW Medical Specialist, Immuno-Oncology/Flex, SCCHN, GBM, Breast, Emerging Tumors, New and Early Asse

Princeton, NJ, United States
May 24, 2019
Required Education
Position Type
Full time

This role will have accountability as the WW Medical Specialist for Immuno-Oncology (I-O)/Flex, supporting the listed tumor teams and New and Early Assets Teams, reporting to the WW Medical SCCHN/GBM/Breast/Emerging Tumors/New and Early Assets Lead. He/she will participate in the cross functional matrix teams to provide scientific and medical support on behalf of WW Medical as well as development and execution of the WW Medical SCCHN/GBM/Breast/Emerging Tumors/NKTR-214 strategy (communication, publication, and ISR strategy).

Responsibilities include: supporting development of medical strategy; leading symposia, congress, and advisory board meeting planning; providing medical input for development of booths, congress materials, and medical information letters; and supporting the execution of publication strategy (abstracts, manuscripts, and congress presentations). He/she will partner closely with medical colleagues in the Markets, with Clinical Research, Regulatory, Commercial, Access, Health Outcomes, Publications, and other key functions.


The successful candidate must be highly professional with excellent relationship-building and communication skills, including the ability to articulate both verbally and in writing complex scientific principles. He/she must have experience working in multifunctional project team and managing external agencies. Additionally have the skills to plan and implement medical congresses and advisory boards. Life sciences and/or healthcare professional training with an advanced degree is require (RN, Pharm. D, MPH, PhD, MD). Prior industry experience in Oncology Medical affairs, Clinical Research or related experience is preferred.